Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Times Interest Earned (2021 - 2025)

Fennec Pharmaceuticals' Times Interest Earned history spans 10 years, with the latest figure at $7.19 for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 843.12% year-over-year to $7.19, compared with a TTM value of -$0.73 through Dec 2025, down 215.49%, and an annual FY2025 reading of -$0.73, down 215.41% over the prior year.
  • Times Interest Earned for Q4 2025 was $7.19 at Fennec Pharmaceuticals, up from -$0.32 in the prior quarter.
  • The five-year high for Times Interest Earned was $13.29 in Q1 2024, with the low at -$1230.8 in Q1 2021.
  • Average Times Interest Earned over 5 years is -$104.02, with a median of -$5.08 recorded in 2024.
  • Year-over-year, Times Interest Earned crashed 327.17% in 2024 and then skyrocketed 843.12% in 2025.
  • Tracing FENC's Times Interest Earned over 5 years: stood at -$75.87 in 2021, then surged by 91.15% to -$6.71 in 2022, then soared by 70.4% to -$1.99 in 2023, then skyrocketed by 51.34% to -$0.97 in 2024, then surged by 843.12% to $7.19 in 2025.
  • Per Business Quant, the three most recent readings for FENC's Times Interest Earned are $7.19 (Q4 2025), -$0.32 (Q3 2025), and -$4.6 (Q2 2025).